Review Article
miR-19 Is a Potential Clinical Biomarker for Gastrointestinal Malignancy: A Systematic Review and Meta-analysis
Table 3
Subgroup analyses were stratified on the basis of histology.
| | Stage | Grade | Lymph node metastasis | Distant metastasis |
| Colorectal cancer | | OR (95% CI) | | OR (95% CI) | | OR (95% CI) | | OR (95% CI) | 6 | 2.74 (1.45, 5.18) | 3 | 1.36 (0.74, 2.51) | 7 | 1.89 (0.99, 3.63) | 8 | 2.02 (0.77, 5.32) | Gastric cancer | | OR (95% CI) | | OR (95% CI) | | OR (95% CI) | | OR (95% CI) | 2 | 0.42 (0.17, 1.04) | 2 | 0.31 (0.14, 0.70) | 3 | 0.46 (0.14, 1.52) | 1 | 0.31 (0.10, 0.97) | Esophagus cancer | | OR (95% CI) | | OR (95% CI) | | OR (95% CI) | | OR (95% CI) | 1 | 1.72 (0.95, 3.12) | 1 | 1.65 (0.86, 3.16) | 1 | 1.87 (0.91, 3.85) | None | None | Liver cancer | | OR (95% CI) | | OR (95% CI) | | OR (95% CI) | | OR (95% CI) | 4 | 0.66 (0.18, 2.45) | 4 | 0.80 (0.47, 1.35) | 1 | 4.75 (1.37, 16.47) | None | None | Pancreatic cancer | | OR (95% CI) | | OR (95% CI) | | OR (95% CI) | | OR (95% CI) | None | None | None | None | None | None | None | None |
|
|
Abbreviations: : study numbers. |